FDA oversight questioned

被引：0

|

作者：

Mitka, Mike

机构：

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2007年 / 298卷 / 22期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：2611 / 2611

页数：1

相关论文

共 50 条

[31] FDA issues oversight rules for medicated feed
Cima, Greg
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2015, 247 (02): : 129 - 129
[32] Pandemic Alters FDA Inspections and Quality Oversight
Wechsler, Jill
Pharmaceutical Technology, 2021, 45 (11) : 14 - 15
[33] FDA Realigns Drug Inspection and Manufacturing Oversight
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2014, 27 (12) : 8 - +
[34] FDA Expands Oversight of Cell and Gene Therapies
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2022, 35 (11) : 9 - 9
[35] FDA faulted for lax oversight of foreign drugs
不详
CHEMICAL & ENGINEERING NEWS, 2008, 86 (17) : 34 - 34
[36] Compounding oversight a work in progress for states, FDA
Traynor, Kate
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (07) : 424 - 425
[37] FDA Oversight of Cell Therapy Clinical Trials
Au, Patrick
Hursh, Deborah A.
Lim, Agnes
Moos, Malcolm C., Jr.
Oh, Steven S.
Schneider, Bruce S.
Witten, Celia M.
SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (149)
[38] Report hits FDA to revamp safety oversight
Finkelstein, Joel B.
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (13) : 884 - 885
[39] Seeking Clarity on FDA Medical Apps Oversight
Mitka, Mike
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (18): : 1847 - 1847
[40] The FDA's poor oversight of postmarketing studies
不详
LANCET, 2009, 374 (9701): : 1568 - 1568

← 1 2 3 4 5 →